Ingalls & Snyder LLC Abcam PLC Transaction History

Ingalls & Snyder LLC

  • $2.56 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$12.98 - $17.1 $138,496 - $182,457
10,670 New
10,670 $144,000
Q3 2021

Oct 27, 2021
SELL
$17.38 - $21.54 $173,800 - $215,400
-10,000 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$18.2 - $22.45 $182,000 - $224,500
10,000 New
10,000 $216,000

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email